Mohammed bin Rashid meets top graduates of MBRU of Medicine
During the meeting, His Highness highlighted the importance of nurturing talent capable of shaping the future of medicine and scientific research in the region. He said the graduates represent key pillars in the UAE's ambition to build a world-class academic and healthcare ecosystem that attracts leading minds from around the globe.
His Highness said, 'We take pride in these achievements, which form part of the broader success story the nation is building. This academic excellence stands as a testament to the UAE's ability to shape the future by nurturing exceptional minds across vital sectors.'
His Highness Sheikh Mohammed added, 'The Mohammed Bin Rashid University of Medicine and Health Sciences has become a beacon of modern knowledge and an incubator for innovation in the healthcare sector. It plays a vital role in preparing future leaders in medicine and scientific research—fully aligned with our vision to position the UAE as a global centre for knowledge and advanced healthcare.'
The meeting was attended by Dr. Raja Easa Al Gurg, Member of the Dubai Health Board of Directors and Chairperson of MBRU Council; Dr. Alawi Alsheikh-Ali, Director General of the Dubai Health Authority; Dr. Amer Sharif, CEO of Dubai Health and President of MBRU; Dr. Hanan Al Suwaidi, Acting Chief Academic Officer of Dubai Health and Provost of MBRU; and members of the MBRU Council.
The 2025 graduating class comprises 164 students from 30 nationalities, across 30 academic programmes. Among them are 129 female graduates, including 52 Emiratis.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Emirates 24/7
2 days ago
- Emirates 24/7
Dubai Charity Association donates AED1.5 million to Dubai Health programmes, initiatives
Dubai Charity Association announced a donation of AED1.5 million to support Dubai Health programmes and initiatives. The donation will benefit Al Jalila Foundation, the philanthropic arm of Dubai Health, and Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), its learning and discovery arm. Of the total amount, AED1 million has been allocated to Al Jalila Foundation's A'awen programme, which provides financial assistance to patients in need of critical medical treatment across the UAE. The remaining AED500,000 will fund medical scholarships at MBRU, supporting the development of future healthcare professionals. The contribution highlights Dubai Charity Association's continued commitment to strengthening healthcare and education, sectors that play a fundamental role in community wellbeing and long-term progress. The generous support was presented by Dubai Charity Association Executive Director Ahmed Ibrahim Al Suwaidi to Dr. Amer Al Zarooni, CEO of Al Jalila Foundation at Dubai Health headquarters, in the presence of Dubai Charity Association Board Vice Chairman Mostafa Karam and Board Member and Treasurer of the Association Eng. Adel Obaid Al Suwaidi. Al Suwaidi commented, 'Our collaboration with Al Jalila Foundation and MBRU reflects a commitment to sustainable development and social wellbeing. We believe in supporting institutions that drive long-term change, and we're confident this contribution will help advance healthcare.' Dr. Al Zarooni affirmed, 'We are proud to partner with Dubai Charity Association, whose support continues to strengthen our mission. Their investment in medical care and education enables us to transform lives and contribute to building a healthcare system that delivers lasting impact. He added that this contribution also aligns with the goals of Dubai Social Agenda 33, which aims to build the most efficient healthcare ecosystem.
Gulf Today
5 days ago
- Gulf Today
Al Jalila Children's Hospital crosses 100 treatments for Spinal Muscular Atrophy
Al Jalila Children's Hospital, part of Dubai Health, and the only children's hospital in the UAE, has completed over 100 treatments for patients with Spinal Muscular Atrophy (SMA). Dr Mohamed Al Awadhi, Executive Director of the Dubai Health Women and Children's Campus, said, "Reaching more than 100 treated cases of SMA reflects Dubai Health's commitment to making world-class care accessible to all children. At Al Jalila Children's Hospital, we follow an integrated, patient-centred approach that supports every phase of the treatment journey. Every step is managed with precision and compassion to put the patient first. Yaqeen's case highlights the strength of our multidisciplinary model and our commitment to ensuring that children with complex conditions like SMA receive the highest standard of care under one roof.' Dr Haitham Elbashir, Consultant Pediatric Neurorehabilitation at Al Jalila Children's Hospital, said, "Zolgensma is a transformative therapy that offers children with SMA the chance to regain strength and function early in life.' The completion of over 100 SMA treatments at Al Jalila Children's reflects the strength of Dubai Health's specialised pediatric services and its commitment to delivering high-quality care for children with complex medical needs. WAM
The National
5 days ago
- The National
Syrian girl receives life-saving treatment as Dubai Ruler covers Dh7 million cost
A young Syrian girl diagnosed with spinal muscular atrophy received Dh7 million gene therapy paid for by Sheikh Mohammed bin Rashid, Vice President and Ruler of Dubai, on Friday at the emirate's Al Jalila Children's Speciality Hospital. Holding a small giraffe toy, and trying to smile, Yaqeen Kankar, sat in the treatment room on Friday morning waiting for the arrival of doctors and her medicine. Two weeks ago, the family made a video appeal on social media for help to save the two-year-old. The office of Sheikh Mohammed called the family saying the Ruler of Dubai would cover the Dh7 million ($1.9 million) cost of medical treatment. Yaqeen's uncle, Ibrahim Abdulaziz Faroj, told The National the family was relieved to know she could now have a normal life. 'We didn't sleep for three days after receiving the happy news that Sheikh Mohammed would cover the cost,' Mr Faroj, 23, said. 'It's a mix of feelings between joy, anticipation and anxiety. We want her to grow normally like any other child. Thanks to Dubai, the dream becomes true.' The uncle had posted a video holding Yaqeen, explaining her condition and asking for help with the cost of her treatment, which is available at only a few centres in the world. 'We know that she has no time. We didn't have other way than to plea for help as we couldn't afford the cost,' Mr Faroj said. Eight months before moving to Dubai, doctors in Syrian diagnosed Yaqeen with spinal muscular atrophy (SMA), a genetic disorder that weakens and wastes muscles. Her parents left no stone unturned seeking help. 'I was posting about her for several months until we received the happy call,' Mr Faroj said. 'It was the best gift ever. We all cried with joy when we heard the news. This action is not strange for the UAE and its rulers who always help people in desperate need.' Doctors gave Yaqeen only months to live without the expensive treatment. Dr Haitham Elbashir, paediatric neurorehabilitation consultant at Al Jalila Children's Hospital, told The National: 'We examined her a week ago and did all the laboratory tests. I'm very happy to say that the medicine is going to be delivered to her today.' Yaqeen underwent the one-hour procedure on Friday morning and will stay in the hospital for 24 hours. Then she can go with her parents to their home in Sharjah. Doctors said they were optimistic it would be successful, but it could take up to three months to see the final results. 'She will need to continue with us for three months because that's the treatment period where we need to follow her regularly,' said Dr Elbashir. Yaqeen was diagnosed with SMA type 2 when she was only six months old. 'Her condition is stable, but she's got some weakness and hopefully the treatment will help to get her better. I'm very optimistic,' said Dr Elbashir. SMA affects the motor neurons (nerve cells that transmit impulses to the muscles) and weakens the limbs. It makes walking difficult or impossible and creates problems with swallowing, as well as breathing. The treatment offered by Al Jalila Children's Hospital, called Zolgensma, is given once and is a form of gene therapy. It was approved by the US Food and Drug Administration four years ago and has been described as the most expensive drug in the world. The hospital has completed more than 100 treatments for patients with SMA, said Dr Mohamed Al Awadhi, executive director of the Dubai Health Women and Children's Campus.
